Señales en vivo de OKYO.L | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 may 2023 @ 11:35):

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom...

Stats
Volumen de hoy	19 575
Volumen promedio	538 135
Capitalización de mercado	23.22M
EPS	£-0.000591 ( Q2 \| 2020-09-30 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-1.400 (Sector) 0 (Industry) 0
ATR14	£0.371 (26.50%)

AMYT.L -11.73%

APH.L -0.13%

AVCT.L -1.49%

AZN.L -0.40%

BMK.L 7.59%

BVXP.L -2.16%

C4XD.L 27.32%

CIR.L 0.00%

CLIN.L 0.11%

DEST.L -2.51%

DPH.L 0.05%

EAH.L 3.40%

ERGO.L 0.15%

ETX.L -6.74%

EVG.L 2.25%

FAB.L -1.59%

FARN.L -5.98%

FUM.L 0.27%

GDR.L 1.10%

GNS.L 1.45%

GSK.L -0.52%

HCM.L -0.36%

HEMO.L -2.66%

HIK.L -0.53%

IMM.L -1.15%

INDV.L 0.00%

IXI.L -5.25%

MTPH.L 1 794.74%

MXCT.L -2.17%

N4P.L -4.71%

NCYT.L -2.42%

NFX.L -5.00%

OBD.L 3.33%

OKYO.L -24.32%

ONC.L 0.45%

OPTI.L -3.63%

OVB.L -2.22%

OXB.L 2.58%

PRM.L -4.82%

PRTC.L 0.98%

PYC.L -6.25%

REDX.L 31.58%

RENE.L -2.17%

SAR.L 8.67%

SCLP.L -1.86%

SLN.L -0.93%

SNG.L 3.48%

STX.L 2.70%

TILS.L 8.33%

TRX.L -1.15%

VAL.L 0.00%

VEC.L 0.00%

Volumen Correlación

Largo: 0.26 (neutral)

Corto: -0.60 (weak negative)

Signal:(35.253) Neutral

OKYO Pharma Ltd Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

OKYO Pharma Ltd Correlación - Moneda/Commodity

0.23
( neutral )

0.41
( neutral )

0.66
( moderate )

-0.20
( neutral )

-0.42
( neutral )

0.31
( neutral )

OKYO Pharma Ltd Finanzas

Annual	2022
Ingresos:	£0
Beneficio Bruto:	£0 (0.00 %)
EPS:	£-0.00420

FY	2022
Ingresos:	£0
Beneficio Bruto:	£0 (0.00 %)
EPS:	£-0.00420

FY	2021
Ingresos:	£0.00
Beneficio Bruto:	£0.00 (0.00 %)
EPS:	£-0.00446

FY	2020
Ingresos:	£0.00
Beneficio Bruto:	£0.00 (0.00 %)
EPS:	£-0.00200

Financial Reports:

No articles found.

OKYO Pharma Ltd Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

OKYO Pharma Ltd

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.